In Heidelberg, researchers have been researching an active ingredient against hepatitis D for decades. The medicine has now been approved by the European Commission. This can give millions of infected hope.
As BW24 * reports, the medicine from Heidelberg has now been approved by the European Commission. The long-term effects of the active ingredient will now be tested in a study.
Researchers at Heidelberg University Hospital are also investigating the new type of coronavirus that has spread around the world. In their studies of those who died of Covid-19, they made an interesting discovery that has to do with the patient’s death (reported BW24 *) * BW24 is part of the Ippen-Digital network